Navigation Links
Bio-Artificial Pancreas Technology to Cure Diabetes Advances

WASHINGTON, Aug. 7, 2013 /PRNewswire-iReach/ -- The Squash Diabetes Campaign, launched by the Georgetown University Women's Squash Team* in December 2012 and sponsored by New Generation Foundation, today announced a $125,000 grant provided by the Chicago-based Chauncey and Marion D. McCormick Family Foundation. The grant will support efforts to launch human trials utilizing new breakthroughs in living-cell bio-artificial pancreas technology and pursue scalable sources of islet cells for transplant recipients.

"In addition to advancing this proven technology, this generous grant raises two important banners," said Tom Gibson, President of New Generation Foundation:

  • "It marks the beginning of our 'public' period, where Squash Diabetes will now be more visible in our advocacy and programmatic work -- beginning this September;
  • It also helps honor the life of the late Mrs. Charlotte McCormick, who had the gift of creative caring and was one of the first private philanthropists to provide major financial support to living-cell encapsulation technology -- to cure diabetes."

New Bio-Artificial "Encapsulife" Pancreas -- Points To A Cure for Diabetes

Successful animal trials in dogs and primates validate the great promise of automatically reversing diabetes, without use harmful immunosuppression drugs. A living-cell bio-artificial pancreas is comprised of encapsulated living islet cells, organized into a "patch." When the living-cell patch is implanted under the skin, it automatically produces insulin in response to glucose stimulation in the diabetic.

The most successful progress in this arena is based on NASA-derived technology discovered and advanced by physicist-astronaut Dr. Taylor Wang, Professor Emeritus of Vanderbilt University and more recently through Dr. Wang's collaboration with Dr. James Markmann, Chief of Transplant Surgery at Massachusetts General Hospital.

To Learn More:

About New Generation Foundation

New Generation Foundation works to raise awareness and funding to support a cure for diabetes and support other programs to promote access to opportunity for young people. New Generation Foundation, is a 501(c)(3) charitable organization based in Washington, D.C.


Media Contact: Thomas Gibson, New generation Foundation, 2023385314,

News distributed by PR Newswire iReach:

SOURCE New Generation Foundation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. JDRF Announces Two Partnerships to Develop Stable, Pumpable Glucagon to Support Advanced Generation Artificial Pancreas Systems
2. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
3. Feasibility of Artificial Pancreas System Demonstrated in Real-World Setting
4. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
5. Cytos Biotechnology Ltd Reports Second Quarter 2013 Financial Results and Recent Developments
6. CAO Group Continues to Lead Innovation With launch of New, High Technology Turbo Forensic Light System
7. Medical Power Supply Market by Technology, Type & Application - Forecasts to 2017
8. University of Virginia Cancer Center Begins Using New Telemedicine Technology for Cervical Cancer Screenings
9. Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)
10. Bode Technology Reaches Sales Milestone of DNA Collectors
11. Frost & Sullivan Finds the Entrenched Nature of qPCR Technology Sustains the US Reagents Market
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... Dublin - ... " Global Markets for Spectroscopy Equipment" report ... This report focuses on the global market of ... applications in various applications. The report deals with spectroscopy ... industries: pharmaceutical and biotechnology, food and beverage, and environmental ...
Breaking Medicine Technology:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
Breaking Medicine News(10 mins):